Skip to main content

Closed

IFRX: InflaRx N.V. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+162.8% / yr

Operating margin-144445.0%

ROIC-112.1%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage-870.7×

Current ratio4.16×

InflaRx N.V.

IFRXNASDAQ Global Select·USD·Closed

InflaRx N.V.

IFRXNASDAQ·USD·Closed

$1.70

−1.16%

$1.70

−$0.02 (1.16%)

52W Range

43thpctl

Volume

0.31×avg

Mkt Cap

122.80MUSD

P/E

-2.4TTM

Div Yield

–ann

52W Range

43thpctl

Volume

0.31×avg

Market Cap

122.80MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings